At AstraZeneca, we have committed to support the truly global effort to fight the COVID-19 pandemic across multiple fronts. The need for an urgent response to the virus has challenged scientists around the world to accelerate the large-scale global clinical investigation and development of potential medicines and vaccines to potentially prevent or treat COVID-19. Normally, the manufacturing of our medicines increases in line with their progression through clinical development and when they are ready for launch commercially, a central supply chain is already in place to support supply.
